Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity.

Nguyen HH, Khathlan A, Fritzler MJ, Swain MG.

BMC Gastroenterol. 2018 Jun 25;18(1):97. doi: 10.1186/s12876-018-0826-7.

2.

Redefining systemic lupus erythematosus - SMAARTT proteomics.

Fritzler MJ, Mahler M.

Nat Rev Rheumatol. 2018 Jun 15. doi: 10.1038/s41584-018-0035-3. [Epub ahead of print] No abstract available.

PMID:
29907860
3.

International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I.

Andrade LEC, Klotz W, Herold M, Conrad K, Rönnelid J, Fritzler MJ, von Mühlen CA, Satoh M, Damoiseaux J, Cruvinel WM, Chan EKL; Executive Committee of ICAP.

Clin Chem Lab Med. 2018 May 29. pii: /j/cclm.ahead-of-print/cclm-2018-0188/cclm-2018-0188.xml. doi: 10.1515/cclm-2018-0188. [Epub ahead of print]

PMID:
29813025
4.

The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination.

Mummert E, Fritzler MJ, Sjöwall C, Bentow C, Mahler M.

J Immunol Methods. 2018 Aug;459:11-19. doi: 10.1016/j.jim.2018.05.014. Epub 2018 May 26. Review.

PMID:
29807021
5.

Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?

Meroni PL, Chan EK, Damoiseaux J, Andrade LEC, Bossuyt X, Conrad K, Mariette X, Sheldon J, Rönnelid J, Fritzler MJ; members of the committees.

Ann Rheum Dis. 2018 Apr 17. pii: annrheumdis-2018-213440. doi: 10.1136/annrheumdis-2018-213440. [Epub ahead of print] No abstract available.

PMID:
29666046
6.

International Consensus on Antinuclear Antibody Patterns: defining negative results and reporting unidentified patterns.

Herold M, Klotz W, Andrade LEC, Conrad K, Cruvinel WM, Damoiseaux J, Fritzler MJ, von Muhlen CA, Satoh M, Chan EKL.

Clin Chem Lab Med. 2018 Apr 10. pii: /j/cclm.ahead-of-print/cclm-2018-0052/cclm-2018-0052.xml. doi: 10.1515/cclm-2018-0052. [Epub ahead of print] No abstract available.

PMID:
29634478
7.

Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).

Nguyen HH, Shaheen AA, Baeza N, Lytvyak E, Urbanski SJ, Mason AL, Norman GL, Fritzler MJ, Swain MG.

PLoS One. 2018 Mar 19;13(3):e0193960. doi: 10.1371/journal.pone.0193960. eCollection 2018.

8.

Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.

Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hüe S, Blockmans D, Mahler M, Fritzler MJ, Bossuyt X.

Autoimmun Rev. 2018 Jun;17(6):533-540. doi: 10.1016/j.autrev.2018.03.002. Epub 2018 Mar 8. Review.

PMID:
29526634
9.

The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies.

Fritzler MJ, Choi MY, Mahler M.

J Rheumatol. 2018 Mar;45(3):444-445. doi: 10.3899/jrheum.170258. No abstract available.

PMID:
29496922
10.

Diagnostic Utility of Anticarbamylated Protein Antibodies as Measured Using Carbamylated Fetal Calf Serum.

Mahler M, Fritzler MJ.

J Rheumatol. 2018 Mar;45(3):438-439. doi: 10.3899/jrheum.170677. No abstract available.

PMID:
29496917
11.

Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies.

Calise SJ, Zheng B, Hasegawa T, Satoh M, Isailovic N, Ceribelli A, Andrade LEC, Boylan K, Cavazzana I, Fritzler MJ, de la Torre IG, Hiepe F, Kohl K, Selmi C, Shoenfeld Y, Tincani A, Chan EKL; IUIS Autoantibody Standardization Committee.

Clin Chem Lab Med. 2018 Feb 26. pii: /j/cclm.ahead-of-print/cclm-2017-1152/cclm-2017-1152.xml. doi: 10.1515/cclm-2017-1152. [Epub ahead of print]

PMID:
29478040
12.

Detection of myositis-specific antibodies: additional notes.

Mahler M, Fritzler MJ.

Ann Rheum Dis. 2018 Feb 14. pii: annrheumdis-2018-213153. doi: 10.1136/annrheumdis-2018-213153. [Epub ahead of print] No abstract available.

PMID:
29444906
13.

Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype.

Fritzler MJ, Hudson M, Choi MY, Mahler M, Wang M, Bentow C, Milo J, Baron M; Canadian Scleroderma Research Group.

Autoimmun Rev. 2018 Mar;17(3):267-275. doi: 10.1016/j.autrev.2018.01.006. Epub 2018 Jan 31. Review.

PMID:
29369808
14.

Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy.

Amlani A, Hazlewood GS, Hamilton L, Satoh M, Fritzler MJ.

Rheumatology (Oxford). 2018 Jan 1;57(1):199-200. doi: 10.1093/rheumatology/kex392. No abstract available.

PMID:
29088473
15.

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.

Hoa S, Troyanov Y, Fritzler MJ, Targoff IN, Chartrand S, Mansour AM, Rich E, Boudabbouz H, Bourré-Tessier J, Albert M, Goulet JR, Landry M, Senécal JL.

Scand J Rheumatol. 2018 May;47(3):210-224. doi: 10.1080/03009742.2017.1334814. Epub 2017 Oct 25.

PMID:
29065773
16.

Emerging technologies in autoantibody testing for rheumatic diseases.

Olsen NJ, Choi MY, Fritzler MJ.

Arthritis Res Ther. 2017 Jul 24;19(1):172. doi: 10.1186/s13075-017-1380-3. Review.

17.

CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts.

Wu M, Baron M, Pedroza C, Salazar GA, Ying J, Charles J, Agarwal SK, Hudson M, Pope J, Zhou X, Reveille JD, Fritzler MJ, Mayes MD, Assassi S.

Arthritis Rheumatol. 2017 Sep;69(9):1871-1878. doi: 10.1002/art.40171. Epub 2017 Aug 8.

PMID:
28575534
18.

Industrial air emissions, and proximity to major industrial emitters, are associated with anti-citrullinated protein antibodies.

Bernatsky S, Smargiassi A, Joseph L, Awadalla P, Colmegna I, Hudson M, Fritzler MJ.

Environ Res. 2017 Aug;157:60-63. doi: 10.1016/j.envres.2017.04.035. Epub 2017 May 17.

PMID:
28525857
19.

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Buyon J, Mahler M, Fritzler MJ.

Lupus. 2017 Sep;26(10):1051-1059. doi: 10.1177/0961203317692437. Epub 2017 Feb 23.

PMID:
28420054
20.

Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.

Mejia Otero C, Assassi S, Hudson M, Mayes MD, Estrada-Y-Martin R, Pedroza C, Mills TW, Walker J, Baron M, Stevens W, Proudman SM, Nikpour M, Mehra S, Wang M, Fritzler MJ; Canadian Scleroderma Research Group; Australian Scleroderma Cohort Study; Genetics versus Environment in Scleroderma Outcome Study.

J Rheumatol. 2017 Jun;44(6):799-805. doi: 10.3899/jrheum.160574. Epub 2017 Apr 1.

21.

Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.

Li G, Adachi JD, Cheng J, Thabane L, Hudson M, Fritzler MJ, Lorenzi S, Baron M, Larché M; Canadian Scleroderma Research Group.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):56-60. Epub 2017 Jan 31.

PMID:
28229818
22.

Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.

Troyanov Y, Landon-Cardinal O, Fritzler MJ, Ferreira J, Targoff IN, Rich E, Goulet M, Goulet JR, Bourré-Tessier J, Robitaille Y, Drouin J, Albert A, Senécal JL.

Medicine (Baltimore). 2017 Jan;96(3):e5694. doi: 10.1097/MD.0000000000005694.

23.

Anti-HMGCR antibodies in systemic sclerosis.

Hudson M, Luck Y, Stephenson M, Choi MY, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG).

Medicine (Baltimore). 2016 Nov;95(44):e5280.

24.

Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.

Zheng B, Vincent C, Fritzler MJ, Senécal JL, Koenig M, Joyal F.

J Rheumatol. 2017 Jan;44(1):33-39. doi: 10.3899/jrheum.160243. Epub 2016 Oct 15.

PMID:
27744398
25.

Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larché M, Abu-Hakima M, Rodriguez-Reyna TS, Cabral-Castaneda AR, Fritzler MJ, Wang M, Hudson M.

Rheumatology (Oxford). 2016 Dec;55(12):2148-2155. Epub 2016 Sep 4.

26.

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Hoa S, Hudson M, Troyanov Y, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Medicine (Baltimore). 2016 Aug;95(35):e4713. doi: 10.1097/MD.0000000000004713.

27.

Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity.

Fritzler MJ, Chan EKL.

Lupus. 2017 Feb;26(2):208-217. doi: 10.1177/0961203316664598. Epub 2016 Aug 20.

PMID:
27539991
28.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.

PMID:
27491568
29.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

30.

Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey.

Bentow C, Fritzler MJ, Mummert E, Mahler M.

Auto Immun Highlights. 2016 Dec;7(1):8. doi: 10.1007/s13317-016-0081-2. Epub 2016 Jul 9.

31.

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.

Choi MY, Fritzler MJ.

Curr Opin Rheumatol. 2016 Nov;28(6):586-94. doi: 10.1097/BOR.0000000000000325. Review.

32.

Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.

Bentow C, Rosenblum R, Correia P, Karayev E, Karayev D, Williams D, Kulczycka J, Fritzler MJ, Mahler M.

Lupus. 2016 Jul;25(8):897-904. doi: 10.1177/0961203316641773.

PMID:
27252267
33.

Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.

Mahler M, Swart A, Wu J, Szmyrka-Kaczmarek M, Senécal JL, Troyanov Y, Hanly JG, Fritzler MJ.

Lupus. 2016 Jul;25(8):889-96. doi: 10.1177/0961203316640918.

PMID:
27252266
34.

Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.

Choi MY, Barber MR, Barber CE, Clarke AE, Fritzler MJ.

Lupus. 2016 Jul;25(8):838-49. doi: 10.1177/0961203316640367. Review.

PMID:
27252260
35.

Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015.

Chan EK, Damoiseaux J, de Melo Cruvinel W, Carballo OG, Conrad K, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Mühlen CA, Andrade LE.

Lupus. 2016 Jul;25(8):797-804. doi: 10.1177/0961203316640920.

PMID:
27252255
36.

Editorial: Are Autoantibodies Involved in the Pathogenesis of Systemic Sclerosis?

Fritzler MJ, Choi MY.

Arthritis Rheumatol. 2016 Sep;68(9):2067-70. doi: 10.1002/art.39727. No abstract available.

37.

Anti-early endosome antigen 1 autoantibodies were detected in a pemphigus-like patient but not in the majority of pemphigus diseases.

Nishikawa R, Takahashi H, Matsuda M, Imaoka K, Ogawa M, Teye K, Tsuchisaka A, Koga H, Komorowski L, Probst C, Hachiya T, Fritzler MJ, Ishii N, Ohata C, Furumura M, Krol RP, Muro Y, Morita E, Hashimoto T.

Exp Dermatol. 2016 May;25(5):368-74. doi: 10.1111/exd.12981.

PMID:
26909655
38.

Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation.

Moghaddas F, Joshua F, Taylor R, Fritzler MJ, Toh BH.

BMC Res Notes. 2016 Feb 11;9:84. doi: 10.1186/s13104-016-1908-7.

39.

International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results.

Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Herold M, Mimori T, Satoh M, Andrade LE, Chan EK, Conrad K.

Auto Immun Highlights. 2016 Dec;7(1):1. doi: 10.1007/s13317-016-0075-0. Epub 2016 Jan 30.

40.

Improving Appropriate Access to Care With Central Referral and Triage in Rheumatology.

Hazlewood GS, Barr SG, Lopatina E, Marshall DA, Lupton TL, Fritzler MJ, Mosher DP, Steber WA, Martin L.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1547-53. doi: 10.1002/acr.22845. Epub 2016 Aug 19.

41.

Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients.

Wu M, Assassi S, Salazar GA, Pedroza C, Gorlova OY, Chen WV, Charles J, Taing ML, Liao K, Wigley FM, Hummers LK, Shah AA, Hinchcliff M, Khanna D, Schiopu E, Phillips K, Furst DE, Steen V, Baron M, Hudson M, Zhou X, Pope J, Jones N, Docherty P, Khalidi NA, Robinson D, Simms RW, Silver RM, Frech TM, Fessler BJ, Fritzler MJ, Molitor JA, Segal BM, Movahedian M, Martín J, Varga J, Mayes MD.

Arthritis Res Ther. 2016 Jan 20;18:20. doi: 10.1186/s13075-016-0923-3.

42.

Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing.

Fritzler MJ.

Autoimmun Rev. 2016 Mar;15(3):272-80. doi: 10.1016/j.autrev.2015.12.002. Epub 2015 Dec 11. Review.

PMID:
26687321
43.

Towards a better understanding of the clinical association of anti-DFS70 autoantibodies.

Mahler M, Meroni PL, Andrade LE, Khamashta M, Bizzaro N, Casiano CA, Fritzler MJ.

Autoimmun Rev. 2016 Feb;15(2):198-201. doi: 10.1016/j.autrev.2015.11.006. Epub 2015 Nov 14. Review.

PMID:
26588998
44.

Detection of autoantibodies using chemiluminescence technologies.

Mahler M, Bentow C, Serra J, Fritzler MJ.

Immunopharmacol Immunotoxicol. 2016;38(1):14-20. doi: 10.3109/08923973.2015.1077461. Epub 2015 Nov 2. Review.

45.

Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls.

Schmeling H, Mahler M, Levy DM, Moore K, Stevens AM, Wick J, McMillan JD, Horneff G, Assassi S, Charles J, Salazar G, Mayes MD, Silverman ED, Klien-Gitelman M, Lee T, Brunner HI, Reed AM, Fritzler MJ.

J Rheumatol. 2015 Dec;42(12):2419-26. doi: 10.3899/jrheum.150567. Epub 2015 Oct 15.

PMID:
26472409
46.

Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015.

Chan EK, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Mühlen CA, Andrade LE.

Front Immunol. 2015 Aug 20;6:412. doi: 10.3389/fimmu.2015.00412. eCollection 2015. Review.

47.

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Tatibouet S, Wang M; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS), Baron M, Fritzler MJ.

Autoimmunity. 2015;48(8):542-51. doi: 10.3109/08916934.2015.1077231. Epub 2015 Aug 31.

PMID:
26334795
48.

Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Cohort Study (ASCS); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S131-5. Epub 2015 Aug 27.

PMID:
26315678
49.

Evidence for Epigenetic Regulation of Gene Expression and Function in Chronic Experimental Diabetic Neuropathy.

Cheng C, Kobayashi M, Martinez JA, Ng H, Moser JJ, Wang X, Singh V, Fritzler MJ, Zochodne DW.

J Neuropathol Exp Neurol. 2015 Aug;74(8):804-17. doi: 10.1097/NEN.0000000000000219.

PMID:
26172287
50.

The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Ochs RL, Mahler M, Basu A, Rios-Colon L, Sanchez TW, Andrade LE, Fritzler MJ, Casiano CA.

Clin Exp Med. 2016 Aug;16(3):273-93. doi: 10.1007/s10238-015-0367-0. Epub 2015 Jun 19. Review.

Supplemental Content

Loading ...
Support Center